Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
28631 | 203 | 31.7 | 39% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
1 | 4 | ECONOMICS//EDUCATION & EDUCATIONAL RESEARCH//PSYCHOL | 3876184 |
17 | 3 | BUSINESS//BUSINESS, FINANCE//MANAGEMENT | 121089 |
624 | 2 | RESEARCH POLICY//JOURNAL OF TECHNOLOGY TRANSFER//PATENTS | 13841 |
28631 | 1 | MCLAUGHLIN ROTMAN GLOBAL HLTH//BIOTECH AND PHARMA INDUSTRIES//ESRC INNOGEN | 203 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | MCLAUGHLIN ROTMAN GLOBAL HLTH | address | 340749 | 8% | 14% | 16 |
2 | BIOTECH AND PHARMA INDUSTRIES | authKW | 300842 | 1% | 100% | 2 |
3 | ESRC INNOGEN | address | 203053 | 4% | 15% | 9 |
4 | AC 2592 | authKW | 150421 | 0% | 100% | 1 |
5 | ACT 280778 | authKW | 150421 | 0% | 100% | 1 |
6 | ADX 415 | authKW | 150421 | 0% | 100% | 1 |
7 | AGRICULTURAL SUSTAINABILITY IN DEVELOPING COUNTRIES | authKW | 150421 | 0% | 100% | 1 |
8 | ANTIHYPERTENSIVES NICOX 1 | authKW | 150421 | 0% | 100% | 1 |
9 | ANTIHYPERTENSIVES NICOX 2 | authKW | 150421 | 0% | 100% | 1 |
10 | ATHEROSCLEROSIS THERAPY LILLY 2 | authKW | 150421 | 0% | 100% | 1 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Management | 387 | 10% | 0% | 20 |
2 | Health Policy & Services | 334 | 7% | 0% | 14 |
3 | Multidisciplinary Sciences | 273 | 6% | 0% | 13 |
4 | Planning & Development | 206 | 4% | 0% | 9 |
5 | Biotechnology & Applied Microbiology | 152 | 13% | 0% | 26 |
6 | Engineering, Chemical | 132 | 12% | 0% | 24 |
7 | Chemistry, Multidisciplinary | 99 | 17% | 0% | 34 |
8 | Health Care Sciences & Services | 72 | 4% | 0% | 9 |
9 | Education, Scientific Disciplines | 65 | 3% | 0% | 6 |
10 | Public, Environmental & Occupational Health | 61 | 8% | 0% | 17 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | MCLAUGHLIN ROTMAN GLOBAL HLTH | 340749 | 8% | 14% | 16 |
2 | ESRC INNOGEN | 203053 | 4% | 15% | 9 |
3 | CLIN CANC INFORMAT | 150421 | 0% | 100% | 1 |
4 | DISTINGUISHED INVESTIGATORS CANADIAN HLTH RE | 150421 | 0% | 100% | 1 |
5 | ENVIRONM SCI EDUC CESE | 150421 | 0% | 100% | 1 |
6 | IMMUNOL SERV INFECT DIS | 150421 | 0% | 100% | 1 |
7 | MCLAUGHLIN ROTMAN GLOBAL HLTHPROGRAM LIFE SC | 150421 | 0% | 100% | 1 |
8 | NCL INNOVAT | 150421 | 0% | 100% | 1 |
9 | PAX HERBAL CLIN | 150421 | 0% | 100% | 1 |
10 | PROGRAM LIFE SCI ETH POLICYMARS | 150421 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | TECHNOLOGY ANALYSIS & STRATEGIC MANAGEMENT | 25809 | 6% | 1% | 13 |
2 | CHEMICAL & ENGINEERING NEWS | 19988 | 11% | 1% | 23 |
3 | BMC INTERNATIONAL HEALTH AND HUMAN RIGHTS | 12360 | 2% | 2% | 5 |
4 | GENETIC ENGINEERING NEWS | 4293 | 2% | 1% | 5 |
5 | BIOTECHNOLOGY LAW REPORT | 4117 | 1% | 1% | 2 |
6 | NATURE BIOTECHNOLOGY | 2805 | 3% | 0% | 7 |
7 | CURRENT SCIENCE | 2522 | 7% | 0% | 15 |
8 | EXPERT OPINION ON INVESTIGATIONAL DRUGS | 2515 | 3% | 0% | 6 |
9 | INDIAN JOURNAL OF PHARMACEUTICAL EDUCATION AND RESEARCH | 2224 | 1% | 0% | 3 |
10 | BIOTECHNOLOGY AND DEVELOPMENT MONITOR | 1633 | 0% | 1% | 1 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | BIOTECH AND PHARMA INDUSTRIES | 300842 | 1% | 100% | 2 | Search BIOTECH+AND+PHARMA+INDUSTRIES | Search BIOTECH+AND+PHARMA+INDUSTRIES |
2 | AC 2592 | 150421 | 0% | 100% | 1 | Search AC+2592 | Search AC+2592 |
3 | ACT 280778 | 150421 | 0% | 100% | 1 | Search ACT+280778 | Search ACT+280778 |
4 | ADX 415 | 150421 | 0% | 100% | 1 | Search ADX+415 | Search ADX+415 |
5 | AGRICULTURAL SUSTAINABILITY IN DEVELOPING COUNTRIES | 150421 | 0% | 100% | 1 | Search AGRICULTURAL+SUSTAINABILITY+IN+DEVELOPING+COUNTRIES | Search AGRICULTURAL+SUSTAINABILITY+IN+DEVELOPING+COUNTRIES |
6 | ANTIHYPERTENSIVES NICOX 1 | 150421 | 0% | 100% | 1 | Search ANTIHYPERTENSIVES+NICOX+1 | Search ANTIHYPERTENSIVES+NICOX+1 |
7 | ANTIHYPERTENSIVES NICOX 2 | 150421 | 0% | 100% | 1 | Search ANTIHYPERTENSIVES+NICOX+2 | Search ANTIHYPERTENSIVES+NICOX+2 |
8 | ATHEROSCLEROSIS THERAPY LILLY 2 | 150421 | 0% | 100% | 1 | Search ATHEROSCLEROSIS+THERAPY+LILLY+2 | Search ATHEROSCLEROSIS+THERAPY+LILLY+2 |
9 | AZD 0837 | 150421 | 0% | 100% | 1 | Search AZD+0837 | Search AZD+0837 |
10 | AZD 1305 | 150421 | 0% | 100% | 1 | Search AZD+1305 | Search AZD+1305 |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | WIELD, D , (2013) BIOECONOMY AND THE GLOBAL ECONOMY: INDUSTRIAL POLICIES AND BIO-INNOVATION.TECHNOLOGY ANALYSIS & STRATEGIC MANAGEMENT. VOL. 25. ISSUE 10. P. 1209-1222 | 9 | 60% | 2 |
2 | THORSTEINSDOTTIR, H , MELON, CC , RAY, M , CHAKKALACKAL, S , LI, M , COOPER, JE , CHADDER, J , SAENZ, TW , PAULA, MCD , KE, W , ET AL (2010) SOUTH-SOUTH ENTREPRENEURIAL COLLABORATION IN HEALTH BIOTECH.NATURE BIOTECHNOLOGY. VOL. 28. ISSUE 5. P. 407 -416 | 8 | 67% | 10 |
3 | CLARK, DE , NEWTON, CG , (2004) OUTSOURCING LEAD OPTIMISATION - THE QUIET REVOLUTION.DRUG DISCOVERY TODAY. VOL. 9. ISSUE 11. P. 492-500 | 9 | 69% | 18 |
4 | CLARK, DE , (2007) OUTSOURCING LEAD OPTIMIZATION: CONSTANT CHANGE IS HERE TO STAY.DRUG DISCOVERY TODAY. VOL. 12. ISSUE 1-2. P. 62-70 | 5 | 100% | 3 |
5 | UCTU, R , JAFTA, RCC , (2014) BIO-ENTREPRENEURSHIP AS A BRIDGE BETWEEN SCIENCE AND BUSINESS IN A REGIONAL CLUSTER: SOUTH AFRICA'S FIRST ATTEMPTS.SCIENCE AND PUBLIC POLICY. VOL. 41. ISSUE 2. P. 219 -233 | 4 | 100% | 0 |
6 | MASUM, H , SINGER, PA , (2010) VENTURE CAPITAL ON A SHOESTRING: BIOVENTURES' PIONEERING LIFE SCIENCES FUND IN SOUTH AFRICA.BMC INTERNATIONAL HEALTH AND HUMAN RIGHTS. VOL. 10. ISSUE . P. - | 5 | 83% | 0 |
7 | NATESH, S , BHAN, MK , (2009) BIOTECHNOLOGY SECTOR IN INDIA: STRENGTHS, LIMITATIONS, REMEDIES AND OUTLOOK.CURRENT SCIENCE. VOL. 97. ISSUE 2. P. 157 -169 | 4 | 100% | 6 |
8 | ABUDUXIKE, G , ALJUNID, SM , (2012) DEVELOPMENT OF HEALTH BIOTECHNOLOGY IN DEVELOPING COUNTRIES: CAN PRIVATE-SECTOR PLAYERS BE THE PRIME MOVERS?.BIOTECHNOLOGY ADVANCES. VOL. 30. ISSUE 6. P. 1589-1601 | 5 | 71% | 3 |
9 | REID, SE , RAMANI, SV , (2012) THE HARNESSING OF BIOTECHNOLOGY IN INDIA: WHICH ROADS TO TRAVEL?.TECHNOLOGICAL FORECASTING AND SOCIAL CHANGE. VOL. 79. ISSUE 4. P. 648 -664 | 9 | 38% | 2 |
10 | CHAKMA, J , MASUM, H , PERAMPALADAS, K , HEYS, J , SINGER, PA , (2011) INDIAN VACCINE INNOVATION: THE CASE OF SHANTHA BIOTECHNICS.GLOBALIZATION AND HEALTH. VOL. 7. ISSUE . P. - | 6 | 55% | 5 |
Classes with closest relation at Level 1 |